Serving the home health, home care and hospice industry since 1999.
Mediware® Acquires Rock-Pond SolutionsAcquisition of longtime partner said to lead to better business intelligence and analytics solutions for the post-acute market
LENEXA, Kan. — August 22, 2018 — Mediware Information Systems, Inc., a portfolio company of TPG Capital and a leading supplier of software solutions in health care and human services, and Rock-Pond Solutions, a business intelligence and analytics software provider for the home infusion, home medical equipment (HME), and specialty pharmacy industries, are pleased to announce that Mediware has acquired Rock-Pond Solutions.
As a longtime trusted Mediware partner, Rock-Pond Solutions has offered business intelligence, analytics, content, tools, and services to many of Mediware’s home infusion, HME, and specialty pharmacy customers. Rock-Pond’s business intelligence and analytics software extends the power of Mediware’s home care solutions. Their leading products — CareTend BI and CareTend BI for CPR+ — provide the meaningful data providers need to drive efficiency, profitability, and quality.
The Rock-Pond acquisition provides Mediware with opportunities for product advancement and optimization, as well as supports more collaborative work on the CareTend product roadmap. Acquiring Rock-Pond further enhances Mediware’s portfolio of industry-leading software solutions. The acquisition uniquely positions Mediware to develop even better business intelligence and analytics solutions that will provide customers with enhanced insights to help them streamline processes and make smarter decisions.
“Rock-Pond Solutions has a proven 17-year track record of providing high-quality business intelligence and analytics solutions to meet the unique requirements of home infusion, HME, and specialty pharmacies. The company’s highly regarded team brings deep experience in post-acute care and they have successfully helped Mediware’s CareTend software become the strong solution it is today,” said Bill Miller, CEO of Mediware. “By acquiring Rock-Pond Solutions, we are strengthening our software offerings to truly help our customers deliver better care to patients across the entire spectrum of post-acute settings by using business intelligence and analytics in meaningful ways.”
Miller told us that this was the easiest acquisition Mediware has made, and there have been many. "We have known Pete and Rock-Pond for a long time," he said. "They work well with our clients and add the element of analytics to our software. Every one of our clients was in favor of the acquisition."
Mediware will combine engineering teams to improve coordination and consistency. Additionally, Mediware plans to accelerate investment in analytics and expertise, beyond CareTend, and continue to drive product innovation.
“Our longtime partnership with Mediware shows that we both have a shared understanding of how business intelligence and analytics helps post-acute facilities streamline decision making and enhance patient care delivery,” said Pete Tanguay, President of Rock-Pond Solutions. “This acquisition will build on our historical success by delivering even better software solutions, business intelligence, and new products.”
Based in Conway, Arkansas, Rock-Pond Solutions is the leading provider of business intelligence and analytics software to the home infusion, HME, and specialty pharmacy industries. Rock-Pond was founded in 2000 as a consulting firm for infusion and specialty pharmacy.
Mediware is a leading supplier of software for health care and human service providers and payers. Core Mediware solutions include blood management technologies for hospitals and blood centers; cell therapy solutions for cord blood banks, cancer treatment centers, and research facilities; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; and rehabilitation therapy and respiratory care solutions.
TPG is a leading global alternative asset firm founded in 1992 with more than $84 billion of assets under management and offices in Austin, Beijing, Boston, Dallas, Fort Worth, Hong Kong, Houston, London, Luxembourg, Melbourne, Moscow, Mumbai, New York, San Francisco, Seoul, and Singapore. TPG’s investment platforms are across a wide range of asset classes, including private equity, growth venture, real estate, credit, and public equity. TPG aims to build dynamic products and options for its investors while also instituting discipline and operational excellence across the investment strategy and performance of its portfolio.
NASHVILLE, Tennessee — August 29 — Amedisys, Inc. (NASDAQ: AMED), today announced it has made a minority equity investment in Medalogix, a Nashville-based Home Health and Hospice predictive modeling and analytics company.
"We are extremely excited about our partnership with Medalogix," said Paul Kusserow, President and CEO of Amedisys. "Aligning ourselves with such an innovative and powerful predictive analytics company will not only help to further optimize our current business and provide even better care to our patients, but also, positions us to succeed in new and differentiated payment models. The Medalogix platform helps drive patient insights needed for risk arrangements and better partnerships with Managed Care Organizations. We look forward to working with them to innovate new products, and helping to shape the strategic direction of the company."
The "shift to value" in the healthcare industry is well underway. CMS has placed focus on the "three-part aim" to: 1) improve individual patient care; 2) provide better health outcomes for populations; and 3) reduce costs. With this charge, home health, guided by technology, stands as an obvious solution, especially as Medicare Advantage enrollment continues to rise and payors seek to form new partnerships that allow patients to receive care in the home and age in place.
"Our industry is in the midst of revolutionary change toward value-based care," said Elliott Wood, President and CEO of Medalogix. "Healthcare providers who excel in this new world will do so by partnering with technology companies who have an aligned focus. We're thrilled to partner with an innovative company like Amedisys who shares a common mission of optimal care for each patient. We look forward to working to together to improve patient care through new paradigms for the industry."
Amedisys partners alongside majority investor Coliseum Capital Management, LLC. Chris Shackelton, Chairman of the Medalogix Board and Managing Partner of Coliseum said, "Over the course of our four-year partnership with Medalogix, Elliott and his team have built a technology that is at the forefront of patient focused analytics in healthcare services. Our partnership with Amedisys, a forward-thinking provider with an aligned vision for value-based care, will expand our strategic capabilities as we continue to grow the industry's only predictive analytics platform for home health."
©2018 by Rowan Consulting Associates, Inc., Colorado Springs, CO. All rights reserved. This article originally appeared in Tim Rowan's Home Care Technology Report. homecaretechreport.com One copy may be printed for personal use; further reproduction by permission only. email@example.com